Helmerich & Payne (NYSE: HP) insider schedules $4.34M stock sale

Rhea-AI Filing Summary

Helmerich & Payne insider plans to sell common stock under Rule 144. A holder has filed to sell 75,000 shares of HP common stock through broker Merrill Lynch, with an aggregate market value of $4,341,000. The filing notes that approximately 98,448,373 shares of common stock were outstanding, and the planned sale is targeted around December 19, 2025 on the NYSE.

The shares to be sold were accumulated over many years, mainly through stock option exercises from 2012–2016 and an inheritance received on January 10, 2012 totaling 50,000 shares. By signing the notice, the seller represents that they are not aware of any material adverse, non-public information about the company’s current or future operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Merrill Lynch 6100 South Yale Ave STE 1500 Tulsa OK 74136	75000	4341000	98448373	12/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	12/07/2016	stock option exercise	Hans Helmerich			2009	12/07/2016	stock option exercise
common	12/06/2013	stock option exercise	hans helmerich			1722	12/06/2013	stock option exercise
common	01/10/2012	inheritance	Walter Helmerich			50000	01/10/2012	n/a
common	12/04/2015	stock option exercise	Hans Helmerich			3731	12/04/2015	stock option exercise
common	12/07/2014	stock option exercise	hans helmerich			2870	12/07/2014	stock option exercise
common	12/06/2014	stocl option exercise	hans helmerich			1722	12/06/2014	stock option exercise
common	12/04/2014	stock option exercise	hans helmerich			2009	12/04/2014	stock option exercise
common	11/25/2014	stock option exercise	hans helmerich			3911	11/25/2014	stock option exercise
common	03/18/2014	stock option exercise	hans Helmerich			4953	03/17/2014	stock option exercise
common	12/07/2013	stock option exercise	hans helmerich			2870	12/07/2013	stock option exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this HP filing disclose about insider share sales?

The filing discloses that an insider plans to sell 75,000 shares of Helmerich & Payne common stock under Rule 144, with an aggregate market value of $4,341,000.

How large is the planned HP share sale compared with shares outstanding?

The notice states that 98,448,373 shares of HP common stock were outstanding, providing context for the planned sale of 75,000 shares.

When and where are the HP shares expected to be sold?

The planned approximate date of sale is December 19, 2025, and the shares are expected to be sold on the NYSE through broker Merrill Lynch in Tulsa, Oklahoma.

How did the HP insider acquire the shares being sold?

The shares were acquired over time mainly through stock option exercises on multiple dates between 2012 and 2016, and through an inheritance of 50,000 shares on January 10, 2012.

Does the HP insider make any representations about non-public information?

Yes. By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

What type of HP security is involved in this planned sale?

The planned sale involves shares of common stock of Helmerich & Payne.